Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study

Documenti analoghi

• Response to Hof et al.: spurious associations between BCG instillations and outcomes in non‐muscle‐invasive bladder cancer
  di: Mattia Longoni, et al.
  Pubblicazione: (2025)
• Acute kidney disease after radical cystectomy for bladder cancer: a new onco‐nephrological view
  di: Francesco Trevisani, et al.
  Pubblicazione: (2025)
• The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidates
  di: Mario de Angelis, et al.
  Pubblicazione: (2025)
• Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: EuroGemDoce group results
  di: Pietro Scilipoti, et al.
  Pubblicazione: (2025)
• The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer
  di: Paolo Zaurito, et al.
  Pubblicazione: (2025)